Jntu Sem 2 r17 Sem 2 Syllabus
Jntu Sem 2 r17 Sem 2 Syllabus
in
I Year – I Semester
Core Elective I
Applied Biopharmaceutics and
Pharmacokinetics
1. Modern Pharmaceutical Analytical
Techniques
25
25
75
75
4
4
--
te
--
s 4
Open Elective I
2. Intellectual Property Rights
1. Pharmacoepidemiology and
Pharmacoeconomics
25
d a 75 4 -- 4
p
2. Drug Regulatory Affairs
3. Herbal Cosmetics Technology
4. Pharmaceutical Validation
Laboratory I
5. Pharmaceutical Management
Advanced physical Pharmaceutics Lab
U 25 75 --- 6 3
ti y
Laboratory II Applied Biopharmaceutics and 25 75 -- 6 3
Pharmacokinetics Lab
Seminar I Seminar 50 -- -- 4 2
I Year – II Semester
e r s
Total Credits 20 16 28
v
Category Course Title Int. Ext. L P C
i
marks marks
Core Course IV Advanced Drug Delivery Systems 25 75 4 -- 4
n
Core Course V
Core Course VI
U
Core Elective II
Open Elective II
Industrial Pharmacy
Modern Pharmaceutics-II
1. Biostatistics And Research
Methodology
2. Stability of Drugs and Dosage Forms
1. Screening Methods in Pharmacology
25
25
25
25
75
75
75
75
4
4
4
4
--
--
--
--
4
4
4
4
2. Nano Based Drug Delivery Systems
3. Nutraceuticals
4. Entrepreneurship management
5. Clinical Research And
Pharmacovigilance
Laboratory III Advanced Drug Delivery Systems Lab 25 75 --- 6 3
Laboratory IV Modern Pharmaceutics Lab 25 75 -- 6 3
Seminar II Seminar 50 -- -- 4 2
Total Credits 20 16 28
II Year - I Semester
II Year - II Semester
te
24
s 12
16
d a
U p
i t y
e r s
n i v
U
Course Objective: The students shall know the pharmacokinetic and pharmacodynamic on the basis
of CDDS. They also know the design evaluation and application related to oral, parenteral,
transdermal, implants, bioadhesives and targeted drug delivery systems.
Course Outcomes:
Students will know the fabrication, design, evaluation and application of above drug delivery systems.
UNIT I
s
Fundamentals of controlled drug delivery systems, pharmacokinetic and pharmacodynamic basis of
controlled drug delivery. Design, fabrication, evaluation and applications of the following controlled
te
releasing systems
a. Controlled release oral drug delivery systems
a
b. Parenteral controlled release drug delivery systems
UNIT II
Design, fabrication, evaluation and applications of the following
a) Implantable Therapeutic systems
b) Transdermal delivery systems
p d
c) Ocular and Intrauterine delivery systems
U
d) Vaccine delivery : Delivery systems used to promote uptake, absorption enhancers, oral
y
immunization, controlled release microparticles form vaccine development
UNIT III
s i t
Biochemical and molecular biology approaches to controlled drug delivery of
a. Bioadhesive drug delivery systems
e r
b. Nasal drug delivery systems
UNIT IV
n
a. Liposomes
b. Niosomes i v
Biochemical and molecular biology approaches to control drug delivery of
c. Microspheres
U
d. Nanoparticles
e. Resealed erythrocytes
UNIT V
Drug targeting to particular organs
a. Delivery to lungs
b. Delivery to the brain and problems involved
c. Drug targeting in neoplasams
Text Books
1. Novel Drug Delivery System by Yie W. Chien.
2. Controlled Drug Delivery by Joseph R. Robinson and Vincent H. L. Lee.
3. Controlled and Novel Drug Delivery Systems by N. K. Jain.
4. Targeted and Controlled Drug Delivery (Novel carrier systems) by S. P. Vyas and Khar.
te s
d a
U p
i t y
e r s
n i v
U
Course Objectives: The students shall learn the theory of unit operations, machinery, materials of
constructions, qualification of equipments and its utility. The students shall also understand about the
objectives and principles of GMP, TQM and effluent analysis and specifications. They also
understand the regulatory basis for the validation of analytical methods related to solids, sterile and
liquid dosage forms
Course Outcome: The students will explain the machinery involved in milling, mixing, filteration,
drying and packing material constructions used in the production of pharmaceutical materials. They
s
also learn salient features of GMP, TQM applicable in industry. They also understand the effluent
treatments and prevent the pollution. They also should evaluate the validation of analytical methods
te
and processes
a
UNIT I
Pharmaceutical unit operations: A detailed study involving machinery and theory of
Pharmaceutical unit operations like milling, mixing, filtration, and drying.
UNIT II
p d
a. Materials of construction of pharmaceutical equipment and packaging materials: Study of the
U
principles, production techniques in the large scale production of tablets, capsules, suspensions,
liquid pharmaceuticals, ophthalmic products, and sterile products.
b. Qualification of equipment (IQ, OQ, PQ)
y
UNIT III
s i t
Production management: Production organization, objectives and policies of good manufacturing
practices, layout of buildings, services, equipments and their maintenance, material management,
e r
handling and transportation, inventory management and control, production and planning control,
Sales forecasting, budget and cost control, industrial and personal relationship. Total Quality
Management (TQM)
UNIT IV
n i v
Effluent Testing and Treatment: Effluent analysis, specifications, and preventive measures water of
pollution, solid pollution, air pollution, and sound pollution.
U
UNIT V
Validation: Regulatory basis, validation of analytical methods, and process, in solid dosage forms,
sterile products, and liquid dosage forms.
TEXT BOOKS:
1. The Theory and Practice of industrial Pharmacy by Leon Lachman, Herbert A. Lieberman.
2. Good Manufacturing Practice for Pharmaceuticals by Sidney H. willig.
3. Pharmaceutical Process validation by Robert A. Nash, Alfred H. Wachter.
4. Modern Pharmaceutics by Gilbert S. Banker and Christopher T. Rhodes.
5. Pharmaceutical production management, C. V. S. Subrahmanyam, Vallabh Prakash.
REFERENCE BOOKS:
1. Unit operations of Chemical Engineering by Warren L. McCabe, Julian C. Smith, Peter
Harriott.
te s
d a
U p
i t y
e r s
n i v
U
Course Objective: The students shall understand about the pilot plant and their scale up techniques
for manufacturing of tablets capsules, suspensions, emulsions and semisolids. The students also
learn the filling of capsules, compression machines, sterilizers for formulation of parenterals and also
understand the properties of propellants, DPI, MDI and their quality control. The students also
understand about the cosmetics and neutraceuticals.
Course Outcomes: students will understand the planning of pilot plant techniques used for all
pharmaceutical dosage forms such as tablets, capsules, parenterals, aerosols, cosmetics and
s
neutraceuticals.
te
UNIT I
Pilot plant scale-up techniques used in pharmaceutical manufacturing
a
a) Pilot plant: Technology transfer from R&D to pilot plant to pilot scale considerations of steps
involved with manufacture, layout design, facility, equipment selection of tablets, capsules,
suspensions, emulsions & semisolids.
p d
b) Scale up: Importance, Scale up process-size reduction, mixing, blending, granulation,
compression, coating involved in tablets, capsules & liquid-liquid mixing.
UNIT II
U
Formulation development of parenteral dosage forms: Advances in materials and production
y
techniques, filling machines, sterilizers, product layout.
UNIT III
s i t
Pharmaceutical Aerosols: Advances in propellants, metered dose inhaler designs, dry powder
inhalers, selection of containers and formulation aspects in aerosols formulation, manufacture and
quality control.
UNIT IV
e r
n i v
Cosmetics: Formulation approaches, preparation & method of manufacturing labeling& Q.C. of anti
ageing products, sun screen lotion and fairness creams.
Nutraceuticals:
a) Introduction, source, manufacture, and analysis of glucosamine and cartinine.
b) Monographs: General and specific properties of glucosamine & cartinine.
U c) A brief overview of role of nutraceuticals in cancer prevention & cardio vascular disorders.
UNIT V
Aseptic processing operation
a) Introduction, contamination control, microbial environmental monitoring, microbiological testing of
water, microbiological air testing, characterization of aseptic process, media and incubation
condition, theoretical evaluation of aseptic operations.
b) Air handling systems: Study of AHUs, humidity & temperature control.
TEXT BOOKS:
1. Pharmaceutics - The Science of Dosage form design by ME Aulton.
2. The Theory and Practice of industrial Pharmacy by Leon Lachman, Herbert A. Lieberman.
3. Remington’s Science and Practice of Pharmacy by A. Gennaro.
4. Ansel’s Pharmaceutical Dosage form and Drug delivery system by Loyd V. Allen, Jr. Nicholas
G. Popovich, Howard C. Ansel.
5. Pharmaceutical Dosage forms - Parenterals (Vol I, II and III) by Avis, Lieberman and
Lachman.
6. Scale up techniques – Pharmaceutical process by Michael Levin, Marcel Dekker
RECOMMENDED BOOKS:
1. Bentley`s Text Book of Pharmaceutics by EA Rawlins.
2. Generic Drug Product Development by Leon Shargel.
3. Dispensing for Pharmaceutical Students by SJ Carter.
4. Modern Pharmaceutics by Gilbert S. Banker and Christopher T. Rhodes.
5. Nutraceuticals, 2nd edition by Brian lock wood.
6. Industrial Pharmacy - Selected Topics , CVS Subramanyam and J Thimmasetty, Vallabh
s
Prakashan Delhi - 2013
a te
p d
y U
s i t
e r
n i v
U
Course Objective: The student shall know the introduction, scope of biostatistics and Research work,
calculation and present of the data. It also informs the students, how the present research work
writing and correlating.
Course Outcome: The student will be known the Biostatistics arrangement, presentation and
formation of tables and charts. They also know the correlation and regression & application of
different methods, analysis of data and also learn how to write dissertation, thesis and Research
paper.
UNIT I
Introduction and scope of biostatistics: Use of statistics in Pharmacy. Population and Sample
te s
collection. Stages of research, types of data and methods of data collections. Data arrangement and
a
presentation, formation of table and charts.
UNIT II
p d
Measures of central tendency: computation of means, median and mode from grouped and
ungrouped data.
Measure of dispersion: computation of variance, standard deviation, standard error and their
coefficients.
UNIT III
y U
t
Measures of Correlation and Regression: Experimental designing, planning of an experiment,
i
replication, and randomization. Probit analysis.
s
Probability rules: Binomial, Poison and Normal distribution.
Hypothesis testing: Student‘t’ test, Chi square test, Analysis of Variance (ANOVA): 1-way, 2-way, 3-
ways
UNIT IV
e r
n i v
Developing a research question, Resources for research question,
Literature Review: Traditional Qualitative Review,
Meta-Analysis—A Quantitative Review
Preparation of Research Proposal
Variables—Definition of Variable, Types of variables (Dependent and Independent variables,
U
Confounded variables), Measurement of variables, Types of measurement scales and their
comparison. Reliability and Validity of Measurements.
UNIT V
The research report paper writing/ thesis writing
Different parts of the research paper
1. Title-Title of project with authors’ name
2. Abstract – Statement of the problem, Background list in brief and purpose and scope
3. Key words
4. Methodology- subject, apparatus, instrumentation and procedure
5. Results – tables, graphs figure and statistical presentation
6. Discussion support or non-support of hypothesis, practical and theoretical implications
7. Conclusion
8. Acknowledgements
9. References
10. Errata
11. Importance of Spell check for entire projects
12. Uses of footnotes
TEXT BOOKS:
1. Deepak Chawla Neena Sondhi, Research Methodology Concepts and Cases, Vikas books
publishers
2. Donald H. McBurney -Theresa L. White “Research Methods” (Cengage learning India Pvt.
Ltd)
REFERENCE BOOKS:
1. Remington”s Pharmaceutical Sciences
s
2. Theory & Practice of Industrial Pharmacy by Lachman
3. Statistics for business and economics 3rd edition by Vikas books publications
te
4. Biostatistics & Computer applications by GN Rao and NK Tiwari
5. Sokal, R.R. and Rohlf, F.J. 1987. An Introduction to Biostatistics. W.H. Freeman and Company.
a
6. Bailey, N.T.J. 1981. Statistical Methods in Biology. English University Press.
7. Mitchell, K. and Glover, T. 2001. Introduction to Biostatistics. McGraw Hill, Publishing Co.
8. Biostatistics and Computer Applications by G.N. Rao and N.K. Tiwari
9. Fundamentals of Biostatistics by Khan and Khanum
10. Research Methodology by R K Khanna bis and Suvasis Saha
11. Research methods and Quantity methods by G. N. Rao
p d
12. A practical approach to PG dissertation.
y U
s i t
e r
n i v
U
10
Course Objective: These topics are designed impart a specialized knowledge to preserve the
properties of drugs and dosage forms during manufacture storage and shelf life. The understanding of
properties and evaluation of stability during storage, by solution and solid state against several factors
of degradation
Course Outcome: The students should describe the evaluation of stability of solutions, solids, and
formulations against adverse conditions. The students should be able to suggest the measures to
retain stability and storage conditions for retaining the efficacy of the products.
UNIT- I
Drug decomposition mechanisms:
1. Hydrolysis and acyltransfers: Nature of reaction, structure and utility, stabilization of
te s
a
Pharmaceutical examples.
2. Oxidation: Nature of oxidation, kinetics of oxidation, oxidation pathways of pharmaceutical,
d
Interest Inhibition of oxidation
3. Photolysis: Energetics of photolysis, kinetics photolysis, photolytic reactions of pharmaceutical
p
interest, prevention of photolytic reactions.
UNIT - II
U
Solid state chemical decomposition: Kinetic of solids state decomposition, Pharmaceutical examples
of solid state decomposition, Pure drugs, drug excipient and drug-drug interaction in solid state,
methods of stabilization.
y
Physical stability testing of dosage forms:
i t
1. Solids – tablets, capsules, powder and granules
2. Disperse systems
3. Microbial decomposition
s
UNIT - III
e r
4. Over-view, physical stability of novel drug carriers, liposomes, niosomes, nano-particles.
v
Identification and quantitative determination of preservatives, Antioxidants, colouring materials,
i
emulsifiers, and stabilizers in Pharmaceutical formulation.
n
Analysis of drugs from biological samples including, selection of biological sample, extraction of drugs
by various methods as LLE, SPE and Membrane filtration. Factors affecting extraction of drugs.
U
UNIT - IV
General method of analysis to determine the quality of raw materials used in cosmetic industry. ..
Indian Standard Specifications (ISI) laid down for sampling and testing of various cosmetics in
finished form by the Bureau of Indian Standards.
UNIT - V
Methods of analysis to determine the quality of cosmetics in the finished forms such as Hair care
products, Skin care products, Baby care products, Dental products, Personal hygiene products,
Colour cosmetics, Ethnic products, Colour makeup preparation, Lipsticks, Hair setting lotions and Eye
shadows. Toxicity testing in cosmetics and Safety and Legislation of Cosmetic products.
Stability studies: Concept of stability studies.
a) cGMP& ICH guidelines for Accelerated stability Testing.
b) Interaction of containers & closure Compatibility Testing.
11
REFERENCE BOOKS:
1. Comprehensive Pharmacy Review 5th Edition by Leon Shargel, Alan H. Mutnick, Paul F.
Souney, Larry N. Sawnson – 2004.
2. H. Beckett and J. B. Stenlake Practical Pharmaceutical Chemistry, Part I and Part II, 4th
Edition. 3. G. H. Jeffery, J. Basset, J. Mendham, R. C. Denny (Rev. by) Vogels Text Book of
Quantitative Chemical Analysis, 5th Edition 1989, ELBS.
3. The Controller of Publications; New Delhi, Govt. of India, Indian Pharmacopoeia, Vol. I and
Vol. II - 2010.
4. J. B. Wilkinson and R. J. Moore: Herry’s Cosmeticology; Longman Scientific and Technical
Publishers, Singapore.
5. P. D. Sethi; Quantitative Analysis of Drugs in Pharmaceutical Formulations, 3rd Edition -
1997,
6. Classification of cosmetics raw materials and adjuncts IS 3958 of Indian Standards Institution
(BIS).
7. Cosmetic and toilet goods – methods of sampling IS 3958 of Indian Standards Institution
(BIS).
8. Methods of sampling and test for various cosmetics as laid down by Bureau of Indian
Standards.
9. Drug stability: Principles and practices by Jens T. Carstensen
te s
10. Stability Testing of Drug Products by W. Grimm. 12. Stability of Drugs and Dosage Forms by
Yoshioka and Stella.
d a
U p
i t y
e r s
n i v
U
12
Course Objective: The students are going to study about various techniques for screening of drugs
for various pharmacological activities and guide lines for handling animals and human and animal
ethics for screening of drugs.
Course Outcome: The expected outcomes are students will know how to handle animals and know
about various techniques for screening of drugs for different pharmacological activities, guidelines and
regulations for screening new drug molecules on animals.
s
UNIT I
Care Handling and breeding techniques of laboratory animals, Regulations for laboratory animals,
te
CPCSEA guidelines, alternatives to animal studies, Good laboratory Practices.
a
UNIT II
Bioassays: Basic principles of Biological standardization: Methods used in the bio-assay of Rabbis
Vaccine, Oxytocin, Tetanus Antitoxin and Diphtheria Vaccine. Test for pyrogens.
UNIT III
p d
Toxicity tests: OECD guidelines, determination of LD50, acute, sub-acute and chronic toxicity studies.
UNIT IV
y U
Organization of screening for the Pharmacological activity of new substances with emphasis on the
t
evaluation of cardiac and anti-diabetic activities.
UNIT V
s i
Organization of screening for the Pharmacological activity of new substances with emphasis on the
r
evaluation of psychopharmacological, anti-inflammatory and analgesic activities.
TEXT BOOKS:
v e
1. Screening methods in Pharmacology, Vol.-1&2 by Robert .A. Turner and Peter Hebborn.
i
2. Drug discovery and evaluation by H. G. Vogel and W. H .Vogel, Springerverlag, Berlin
n
Heideleberg.
3. Handbook of experimental pharmacology by S. K. Kulkarni, Vallabh Prakashan, Delhi.
U
REFERENCE BOOKS:
1. ICH of technical requirements for registration of pharmaceuticals for human use, ICH
harmonized tripartite guidelines - Guidelines for good clinical practice, E6, May 1996.
2. Good clinical practice - Guidelines for Clinical trials on pharmaceutical products in India,
Central drug standard control organization, New Delhi, Minister of Health- 2001.
13
Course Objective - To develop expertise regarding suitability and evaluation of nanomaterials, able
to apply the properties to the fabrication of nanopharmaceutical, evaluate the intensity of dosage
forms and availability for targeting and controlled delivery.
Course Outcomes – The students should be able to select the right kind of materials, able to develop
nano formulations with appropriate technologies, evaluate the product related test and for identified
diseases
s
UNIT I – Introduction to Nanotechnology
Definition of nanotechnology
te
History of nanotechnology
Unique properties of nanomaterials
d a
Role of size and size distribution of nanoparticles properties, classification.
p
a) Physical, chemical and biological Methods
b) Methods for sysnthesis of
Gold nanoparticles
Magnetic nanoparticles
Polymeric nanoparticles
Self – assembly structures such
y as
U
liposomes, micelles, aquasomes and
nanoemulsions
s i t
UNIT III – Biomedical applications of Nanotechnology
r
a) Nanotechnology products used for in vitro diagnostics
b) Improvements to medical or molecular imaging using nanotechnology
UNIT IV
i e
c) Targeted nanomaterials for diagnostic and therapeutic purpose
v
Design of nanomaterials for drug delivery, pulmonary and nasal drug delivery, nanomaterials for
UNIT V
n
cancer therapy and cardiovascular diseases. Localized drug delivery systems.
U
Characterization including the principles, size reduction, analysis of nanoparticles, size, PDI, size
separation, stability, methods of analysis regarding integrity and release of drugs
RECOMMENDED BOOKS:
1. Nanomedicine and Nanoproducts: Applications, Disposition and Toxicology in the Human
body, Eiki Igarashi, CRC press. 2015
2. Nanotechnology and Drug Delivery Volume one and two: Nanoplatforms in Drug Delivery,
Jose L. Arias, CRC press
3. Nano: The Essentials: Understanding Nanosicence and Nanotechnology, T.Pradeep, Tata
McGraw-Hill Publishing Company Limited, New Delhi, 2008.
4. Nanocrystals: Synthesis, Properties and Applications, C. N. R. Rao, P. J. Thomas and G.U.
Kulakarni, Springer (2007)
5. Nanostructures and Nanomaterilas: Synthesis, Properties and Application, Guozhong Gao,
Imperial College Press(2004)
14
te s
d a
U p
i t y
e r s
n i v
U
15
Course Objectives: The students will expose to characteristic features of various phytochemicals as
neutraceuticals in various diseased conditions and also know the role of antioxidant in free radical
induced disease conditions and will expose to various food laws and regulations
Course Outcome: Helps the student to understand the importance of Neutraceuticals in various
common problems with the concept of free radicals.
UNIT I
s
a. Definitions of Functional foods, Nutraceuticals and Dietary supplements. Classification of
Nutraceuticals, Health problems and diseases that can be prevented or cured by Nutraceuticals
te
i.e. weight control, diabetes, cancer etc.
b. Source, Name of marker compounds and their chemical nature, Medicinal uses and health
a
benefits of following used as nutraceuticals/functional foods:
Spirulina, Soyabean, Ginseng, Garlic, Broccoli, Gingko, Flaxseeds
UNIT II
p d
Phytochemicals as neutraceuticals: Occurrence and characteristic features(chemical nature medicinal
benefits) of following
y U
a) Carotenoids- α and β-Carotene, Lycopene, Xanthophylls, lutein
t
d) Flavonoids- Rutin , Naringin, Quercitin, Anthocyanidins, catechins, Flavones
i
e) Prebiotates / Probiotics.: Fructo oligosaccharides, Lacto bacillum
s
f) Phytoestrogens : Isoflavones, daidzein, Geebustin, lignans
r
g) Tocopherols
UNIT III
v e
a) Introduction to free radicals: Free radicals, reactive oxygen species, production of free radicals in
i
cells, damaging reactions of free radicals on lipids, proteins, Carbohydrates, nucleic acids.
b) Measurement of free radicals: Lipid peroxidation products, lipid hydroperoxide, malondialdehyde.
UNIT IV
U n
a. Free radicals in Diabetes mellitus, Inflammation, Ischemic reperfusion injury, Cancer,
Atherosclerosis, Free radicals in brain metabolism and pathology, kidney damage, muscle
damage. Free radicals involvement in other disorders. Free radicals theory of ageing.
b. Antioxidants: Endogenous antioxidants – enzymatic and nonenzymatic antioxidant defence,
Superoxide dismutase, catalase, Glutathione peroxidase, Glutathione Vitamin C, Vitamin E,
α- Lipoic acid, melatonin
Synthetic antioxidants: Butylatedhydroxy Toluene, Butylatedhydroxy Anisole.
UNIT V
Food Laws and Regulations; FDA, FPO, MPO, AGMARK. HACCP and GMPs on Food Safety.
Adulteration of foods.
Regulations and Claims – Current Products: Label Claims, Nutrient Content Claims, Health Claims,
Dietary Supplements Claims
16
REFERENCES:
1. Dietetics by Sri Lakshmi
2. Role of dietary fibres and neutraceuticals in preventing diseases by K. T Agusti and P. Faizal:
BS Publication.
3. Advanced Nutritional Therapies by Cooper. K. A., (1996).
4. The Food Pharmacy by Jean Carper, Simon & Schuster, UK Ltd., (1988).
nd
5. Prescription for Nutritional Healing by James F. Balch and Phyllis A. Balch 2 Edn. Avery
Publishing Group, NY (1997).
6. G. Gibson and C. Williams Editors 2000 Functional foods Woodhead Publ. Co. London.
7. Goldberg, I. Functional Foods. 1994. Chapman and Hall, New York.
8. Labuza, T. P. 2000 Functional Foods and Dietary Supplements: Safety, Good Manufacturing
Practice (GMPs) and Shelf Life Testing in Essentials of Functional Foods M. K. Sachmidl and
T. P. Labuza eds. Aspen Press.
s
9. Handbook of Nutraceuticals and Functional Foods, Third Edition (Modern Nutrition)
10. Shils, ME, Olson, JA, Shike, M. 1994 Modern Nutrition in Health and Disease. Eighth edition.
te
Lea and Febiger
d a
U p
i t y
e r s
n i v
U
17
Course Objective: This course is designed to impart knowledge and skills necessary to train the
students on entrepreneurship management.
Course Outcome: On completion of this course it is expected that students will be able to
understand,
The Role of enterprise in national and global economy
Dynamics of motivation and concepts of entrepreneurship
Demands and challenges of Growth Strategies And Networking
UNIT I
Conceptual Frame Work: Concept need and process in entrepreneurship development. Role of
te s
enterprise in national and global economy. Types of enterprise – Merits and Demerits. Government
a
policies and schemes for enterprise development. Institutional support in enterprise development and
management.
UNIT II
p d
Entrepreneur: Entrepreneurial motivation – dynamics of motivation. Entrepreneurial competency –
Concepts. Developing Entrepreneurial competencies - requirements and understanding the process
y U
of entrepreneurship development, self-awareness, interpersonal skills, creativity, assertiveness,
UNIT III
i t
Launching And Organizing An Enterprise: Environment scanning – Information, sources, schemes of
s
assistance, problems. Enterprise selection, market assessment, enterprise feasibility study, SWOT
r
Analysis. Resource mobilization -finance, technology, raw material, site and manpower. Costing
and marketing management and quality control. Feedback, monitoring, and evaluation.
UNIT IV
i v e
Growth Strategies And Networking: Performance appraisal and assessment. Profitability and control
measures, demands and challenges. Need for diversification. Future Growth – Techniques of
U
UNIT V n
expansion and diversification, vision strategies. Concept and dynamics. Methods, Joint venture, co-
ordination and feasibility study.
Preparing Project Proposal to Start on New Enterprise Project work – Feasibility report; Planning,
resource mobilization and implementation.
18
Course Objective: This subject will provide a value addition and current requirement for the students
in clinical research and pharmacovigilance. It will teach the students on conceptualizing, designing,
conducting, managing, and reporting of clinical trials. This subject also focuses on global scenario of
pharmacovigilance in different methods that can be used to generate safety data. It will teach the
students in developing drug safety data in pre-clinical, clinical phases of drug development and post
market surveillance.
Course Outcome: Upon completion of the course, the student shall be able to,
s
Explain the regulatory requirements for conducting clinical trial
te
Demonstrate the types of clinical trial designs
Explain the responsibilities of key players involved in clinical trials
Execute safety monitoring, reporting and close-out activities
Explain the principles of Pharmacovigilance
Detect new adverse drug reactions and their assessment
Perform the adverse drug reaction reporting systems and
d acommunication in
p
pharmacovigilance
UNIT - I
U
Regulatory Perspectives of Clinical Trials: Origin and Principles of International Conference on
Harmonization - Good Clinical Practice (ICH-GCP) guidelines Ethical Committee: Institutional Review
y
Board, Ethical Guidelines for Biomedical Research and Human Participant-Schedule Y, ICMR,
s i t
Informed Consent Process: Structure and content of an Informed Consent Process Ethical principles
r
UNIT - II
Clinical Trials: Types and Design: Experimental Study- RCT and Non RCT, Observation Study:
e
Cohort, Case Control, Cross sectional Clinical Trial Study Team Roles and responsibilities of Clinical
v
Trial Personnel: Investigator, Study Coordinator, Sponsor, Contract Research Organization and its
management.
i
UNIT - III
n
Clinical Trial Documentation: Guidelines to the preparation of documents, Preparation of protocol,
U
Investigator Brochure, Case Report Forms, Clinical Study Report Clinical Trial Monitoring-Safety
Monitoring in CT Adverse Drug Reactions: Definition and types. Detection and reporting methods.
Severity and seriousness assessment. predictability and preventability assessment. Management of
adverse drug reactions; Terminologies of ADR.
UNIT- IV
Basic aspects, terminologies, and establishment of pharmacovigilance:
History and progress of pharmacovigilance, Significance of safety monitoring, Pharmacovigilance in
India and international aspects, WHO international drug monitoring programme, WHO and Regulatory
terminologies of ADR, evaluation of medication safety, Establishing pharmacovigilance centres in
Hospitals, Industry and National programmes related to pharmacovigilance. Roles and responsibilities
in Pharmacovigilance.
19
UNIT - V
Methods, ADR reporting and tools used in pharmacovigilance:
International classification of diseases, International Nonproprietary names for drugs, Passive and
Active surveillance, Comparative observational studies, targeted clinical investigations and Vaccine
safety surveillance. Spontaneous reporting system and Reporting to regulatory authorities, Guidelines
for ADRs reporting. Argus, Aris G Pharmacovigilance, VigiFlow, Statistical methods for evaluating
medication safety Data.
REFERENCES:
1. Central Drugs Standard Control Organization- Good Clinical Practices, Guidelines for Clinical
Trials on Pharmaceutical Products in India. New Delhi: Ministry of Health; 2001.
2. International Conference on Harmonization of Technical requirements for registration of
Pharmaceuticals for human use. ICH Harmonized Tripartite Guideline. Guideline for Good
s
Clinical Practice. E6; May 1996.230
3. Ethical Guidelines for Biomedical Research on Human Subjects 2000. Indian Council of
te
Medical Research, New Delhi.
4. Textbook of Clinical Trials edited by David Machin, Simon Day and Sylvan Green, March
a
2005, John Wiley and Sons.
5. Clinical Data Management edited by R K Rondels, S A Varley, C F Webbs. Second Edition,
Jan 2000, Wiley Publications.
p d
6. Handbook of clinical Research. Julia Lloyd and Ann Raven Ed. Churchill Livingstone.
7. Principles of Clinical Research edited by Giovanna di Ignazio, Di Giovanna and Haynes.
8. Textbook of PHarmacovigilance: Concept and Practice. G. P. Mohanta and P. K. Manna.
2016, Pharma Med Press.
U
9. A textbook of Clinical Pharmacy Practice: Essential Concepts and Skills. Second Edition,
2012, University Press
y
s i t
e r
n i v
U
20
List of Experiments
1. Study on diffusion of drugs through various polymeric membranes (2 experiments)
2. Formulation and evaluation of sustained release oral matrix tablet (2 experiments)
3. Formulation and evaluation of sustained release oral reservoir system. (2 experiments)
4. Formulation and evaluation of microspheres / microencapsules (2 experiments)
5. Study of in-vitro dissolution of various SR products in market (2 experiments)
6. Formulation and evaluation of transdermal films (2 experiments)
7. Formulation and evaluation mucoadhesive system (2 experiments)
s
8. Preparation and evaluation enteric coated pellets / tablets. (2 experiments)
a te
p d
y U
s i t
e r
n i v
U
21
List of Experiments
1. Preparation of four different types of semisolid forms and evaluation of their performance
using in vitro diffusion method
2. Evaluation of test sterility for commercial preparations including sterile water for injection and
antibiotic injection.
3. Collecting samples of environment of aseptic room and counting the colonies
4. Validation of one unit operation (eg. Mixing) and development of protocol.
5. Comparative evaluation of different marketed products (tablets) of the same API
s
6. Dissolution studies of drug in three different bio relevant dissolution media
7. Stability study testing of tablet dosage forms (Any two products)
a te
p d
y U
s i t
e r
n i v
U
22